BioNotebook: Medicines Company, NPS report 2013 earnings; CURx licenses Gilead drug
This article was originally published in Scrip
Executive Summary
The Medicines Company (MDCO) and NPS Pharmaceuticals saw their stocks close down slightly following largely positive fourth quarter and year-end 2013 financial reports.